WHWK
WHWK
NASDAQ · Biotechnology

Whitehawk Therapeutics Inc

$2.76
+0.05 (+1.85%)
As of Feb 8, 2:09 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +527.2% upside
Low Target $14.24
Average Target $17.31
High Target $28.90
Current Price $2.76
Current
$2.76
Target
$17.31
$14.24 $17.31 avg $28.90
Scenario Analysis
Bear Case
$14.24
415.9%
Low target
Base Case
$17.31
+527.2%
Avg target
Bull Case
$28.90
+947.1%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$21.14
-86.9% from high
52-Week Low
$13.43
+-79.4% from low
Target vs 52W High
$17.31
-18.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%